Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.

ABSTRACT:

Purpose

We characterized factors related to nondefinitive management (NDM) of patients with high-risk prostate cancer and assessed impact from race, insurance status, and facility-level volume of technologically advanced prostate cancer treatments (i.e., intensity-modulated radiation therapy, robotic-assisted laparoscopic radical prostatectomy) on this outcome.

Methods

We identified men with high-risk localized prostate cancer (based on D׳Amico criteria) in the National Cancer Database (2010-2012). Primary outcome was NDM (i.e., delayed/no treatment with prostatectomy/radiation therapy or androgen-deprivation monotherapy). Treating facilities were classified by quartiles of proportions of patients treated with advanced technology. Multivariable regression estimated odds of p

SUBMITTER: Gerhard RS 

PROVIDER: S-EPMC5400671 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature